6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.

Source:http://linkedlifedata.com/resource/pubmed/id/11495584

J. Med. Chem. 2001 Aug 16 44 17 2719-34

Download in:

View as

Triples

General Info

PMID
11495584